Bio: Melissa Butterworth is the Co-Founder, Managing Director, and President of Advanced Strategic Partners, a mergers and acquisitions (M&A) firm composed of executives from the laboratory industry, each of whom has 10 years of experience in that industry, differentiating their team from anyone else in the M&A lab market.
Butterworth has 26 years of experience specific to the laboratory industry, the last eleven of which were spent in the M&A sector. She has completed over $1.2B in clinical, anatomical, molecular and hospital outreach laboratory transactions during her career.
In addition to her M&A expertise, Butterworth has spent the last decade advising molecular laboratories on new business development initiatives. As part of these initiatives, she served as the worldwide Sales & Marketing VP for PhenoPath Laboratory, overseeing both their clinical laboratory and the CRO division.
Butterworth is currently working with NeoGenomics as a consultant on strategic initiatives. She’s the author of The End Game, A Laboratory Owner’s Exit Strategy, now available on Amazon.com. She graduated with honors from the University of North Florida with dual degrees in marketing and management.